| PERIOD ENDING | 28-Mar-09 | 29-Mar-08 | 31-Mar-07 | | Total Revenue | 75,419 | 70,453 | 66,473 | | Cost of Revenue | 56,671 | 51,912 | 49,783 | | | Gross Profit | 18,748 | 18,541 | 16,690 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 16,062 | 15,258 | 14,341 | | Non Recurring |
-
|
-
| (1,544) | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 2,686 | 3,283 | 3,893 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (67) | (437) | (283) | | Earnings Before Interest And Taxes | 2,619 | 2,846 | 3,610 | | Interest Expense | 100 | 101 | 334 | | Income Before Tax | 2,519 | 2,745 | 3,276 | | Income Tax Expense | 963 | 382 | 1,217 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,556 | 2,363 | 2,059 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 1,556 | 2,363 | 2,059 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,556 | $2,363 | $2,059 |
|
0.18% Nasdaq 
0.42%
Income Statement
